文献速递心力衰竭与心肌病高血压

心力衰竭的预防

Prevention of heart failure.
PubMed 文献 · Eur Heart J · 2026-01-01

本文为欧洲心脏病学会(ESC)的科学声明,更新了心力衰竭(HF)预防的视角。内容指出,尽管诊疗策略进步,HF仍是全球主要死因和医疗负担,预防需多学科综合策略。声明强调需关注合并症和危险因素(如高血压、慢性肾病、糖尿病等)、生活方式及环境社会经济因素,并重视肿瘤治疗相关心脏毒性及疫苗保护作用。

要点

  • HF预防需采取多学科、整体化和个体化的综合管理策略
  • 重点关注代谢紊乱、糖尿病和肾脏疾病等新兴HF表型驱动因素
  • 预防应涵盖危险因素控制、疫苗保护及环境社会经济因素

核心结论

  • 预防心衰需采用多学科、整体化和个体化的方法,综合管理多种合并症和危险因素

研究设计与样本

  • 本文为ESC的科学声明,基于对最新证据的综述,更新2021年ESC心衰指南和2022年相关立场文件的预防观点

主要发现

  • 心衰患者表型发生变化,冠状动脉疾病影响降低,肾脏和代谢因素作用增加,主要导致射血分数保留的心衰
  • 预防心衰需考虑高血压、慢性肾病、糖尿病、久坐生活方式、肥胖、血脂异常、女性特异性危险因素,以及放化疗的不良反应
  • 感染和疫苗接种的保护作用,以及环境和社会经济健康决定因素也是关键因素

关键数值与推荐

  • 自2022年立场文件以来,在代谢紊乱、糖尿病和肾脏疾病背景下预防心衰方面出现了重要新证据

临床怎么用

  • 临床实践中应优先加强预防措施,采用多学科策略覆盖广泛共病和危险因素
  • 需关注心衰表型变化,重视肾脏和代谢因素在预防中的角色

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heart failure (HF) remains a major cause of morbidity, mortality and costs for the healthcare systems worldwide, despite advances in diagnostic and therapeutic strategies. The enhancement of preventive measures is now a priority, but effective prevention requires a multidisciplinary strategy addressing a broad spectrum of comorbidities and risk factors. It must also consider the changes in the prevailing phenotype of the patients with HF with a lower impact of coronary artery disease and the increasing role of renal and metabolic conditions leading mostly to HF with preserved ejection fraction. Prevention of HF must take into consideration arterial hypertension, chronic kidney disease, diabetes mellitus, sedentary lifestyle, obesity, dyslipidemia, female-specific risk factors, as well as adverse effects of chemotherapy and radiotherapy. Other key factors include infections and the protective role of vaccination, and environmental and socio-economic determinants of health. In 2022, a position paper of the Heart Failure Association and the European Association of Preventive Cardiology of the ESC was published as a complete overview on this topic and as a compendium to the 2021 ESC Guidelines on HF. However, since then, significant evidence has emerged regarding the potential to prevent HF, particularly in the context of metabolic disorders, diabetes and kidney diseases. This scientific statement aims to provide an updated perspective, highlighting the importance of a holistic and tailored approach to managing the multifaceted contributors to this syndrome.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Piepoli, Rosano, Abreu, et al. Prevention of heart failure. Eur Heart J. 2026. PMID: 42216242. doi:10.1093/eurheartj/ehag362

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。